Segall Bryant & Hamill LLC Purchases 2,865 Shares of Balchem Co. (NASDAQ:BCPC)

Segall Bryant & Hamill LLC increased its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 8.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,616 shares of the basic materials company's stock after acquiring an additional 2,865 shares during the quarter. Segall Bryant & Hamill LLC owned about 0.11% of Balchem worth $5,968,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Arizona State Retirement System lifted its stake in shares of Balchem by 0.8% in the fourth quarter. Arizona State Retirement System now owns 9,413 shares of the basic materials company's stock valued at $1,534,000 after buying an additional 77 shares during the period. Heritage Family Offices LLP grew its holdings in shares of Balchem by 8.3% during the 4th quarter. Heritage Family Offices LLP now owns 1,420 shares of the basic materials company's stock worth $231,000 after purchasing an additional 109 shares in the last quarter. Inspire Investing LLC increased its position in shares of Balchem by 4.9% during the fourth quarter. Inspire Investing LLC now owns 2,462 shares of the basic materials company's stock valued at $401,000 after purchasing an additional 114 shares during the period. Westside Investment Management Inc. acquired a new position in shares of Balchem in the third quarter valued at $27,000. Finally, Inspire Advisors LLC lifted its position in Balchem by 3.2% in the fourth quarter. Inspire Advisors LLC now owns 5,123 shares of the basic materials company's stock worth $835,000 after purchasing an additional 161 shares during the period. 87.91% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

BCPC has been the subject of a number of recent research reports. Sidoti upgraded shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. StockNews.com downgraded Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, HC Wainwright reissued a "buy" rating and issued a $190.00 target price on shares of Balchem in a report on Monday, February 24th.

Balchem Price Performance

BCPC stock traded up $2.21 during trading on Monday, hitting $166.00. 278,079 shares of the stock traded hands, compared to its average volume of 122,693. The stock has a market cap of $5.40 billion, a price-to-earnings ratio of 42.24, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a one year low of $137.69 and a one year high of $186.03. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The company has a 50 day simple moving average of $165.37 and a 200 day simple moving average of $169.27.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to the consensus estimate of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. Equities analysts expect that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.